PharmaShots Weekly Snapshot (Aug 31 – Sept 04, 2020)

 PharmaShots Weekly Snapshot (Aug 31 – Sept 04, 2020)

1. AbbVie to License I-Mab’s Lemzoparlimab (TJC4) for ~$2B

Published: Sept 04, 2020 | Tags: AbbVie, License, I-Mab, Lemzoparlimab, (TJC4), ~$2B

2. Kite and HiFiBiO Therapeutics Collaborate to Develop Antibodies Targeting Acute Myeloid Leukemia

Published: Sept 03, 2020 | Tags: Kite, HiFiBiO Therapeutics, Collaborate, Antibodies, Targeting, Acute Myeloid Leukemia

3. Abbott Initiates LIFE-BTK Trial to Evaluate the Esprit BTK Drug-Eluting Resorbable Scaffold

Published: Sept 03, 2020 | Tags: Abbott, Initiates, LIFE-BTK Trial, Evaluate, the Esprit BTK, Drug-Eluting Resorbable Scaffold

4. Innovent’s Sulinno (biosimilar, adalimumab) Receives NMPA’s Approval for Autoimmune Diseases

Published: Sept 03, 2020 | Tags: Innovent, Sulinno, (biosimilar, adalimumab, Receives, NMPA, Approval, Autoimmune Diseases

5. Roche Receives the US FDA’s EUA for cobas SARS-CoV-2 and Influenza A/B Test

Published: Sept 04, 2020   | Tags: Roche, Receives, US, FDA, EUA, cobas SARS-CoV-2, Influenza A/B Test

6. Eli Lilly’s Trulicity (dulaglutide) Receives the US FDA’s Approval for Additional Doses to Treat Type 2 Diabetes

Published: Sept 03, 2020 | Tags: Eli Lilly, Trulicity, (dulaglutide), Receives, US, FDA, Approval, Additional Doses, Treat, Type 2 Diabetes

7. Bio-Thera Initiates P-I Study of BAT2206 Proposed Biosimilar to Stelara (ustekinumab)

Published: Sept 03, 2020 | Tags: Bio-Thera, Initiates, P-I, Study, BAT2206, Proposed Biosimilar, Stelara, (ustekinumab)

8. Bicycle Reports First Patient Dosing in P-IIa Study of BT1718 for MT1-MMP-Positive Squamous NSCLC

Published: Sept 02, 2020 | Tags: Bicycle, Reports, First Patient Dosing, P-IIa, Study,  BT1718

9. Baxter’s Theranova Dialyzers Receives the US FDA’s De Novo Authorization to Deliver HDx Therapy

Published: Sept 03, 2020 | Tags: Baxter, DE Novo, Authorization, FDA,    Receives, Theranova, Dialyzers, US

10. Janssen Halts the Development of Pimodivir for Influenza

Published: Sept 02, 2020 | Tags: Development, Halts, Influenza, Janssen, Pimodivir

11. Merck Signs a Second Oncology Collaboration with Highlight Therapeutics

Published: Sept 02, 2020 | Tags: Merck, Signs, Second, Oncology, Collaboration, Highlight, Therapeutics

12. Boehringer Ingelheim Collaborates with BiomX to Discover Microbiome-Based Biomarkers for Inflammatory Bowel Disease

Published: Sept 02, 2020 | Tags: BiomX, Boehringer Ingelheim, Collaborates, Discover, Inflammatory Bowel Disease, Microbiome-Based, Biomarkers

13. Sanofi And GSK Initiate P-I/II Study of COVID-19 Protein-Based Vaccine

Published: Sept 03, 2020 | Tags: COVID-19, GSK, Initiate, P-I/II, Protein Based, Vaccine, Sanofi, Study

14. Idorsia Transfers its Agreement with ReveraGen to Santhera for Vamorolone

Published: Sept 02, 2020 | Tags: Agreement, Idorsia, ReveraGen, Santhera, Transfers, Vamorolone

15. BMS’ Onureg (azacitidine) Receives the US FDA’s Approval as Continued Treatment for Acute Myeloid Leukemia

Published: Sept 02, 2020 | Tags: Azacytidine, Acute Myeloid Leukemia, Approval, BMS, Continued, Treatment, FDA, Onureg, Receives, US

16. AstraZeneca’s Imfinzi (durvalumab) Receives EC’s Approval as 1L Treatment for Extensive-Stage Small Cell Lung Cancer

Published: Sept 01, 2020 | Tags: durvalumab, ES-SCLC, AstraZeneca, Extensive-Stage, Small Cell Lung Cancer, Imfinzi, Receives

17. Nestlé to Acquire Aimmune Therapeutics for $2.6B

Published: Aug 31, 2020 | Tags: $2.6B, Acquire, Aimmune Therapeutics, Nestlé

18. Medtronic’s MiniMed 770G Insulin Pump System with Smartphone Connectivity Receives the US FDA’s Approval for Patients with Type 1 Diabetes

Published: Sept 01, 2020 | Tags:  Approval, Connectivity, FDA, Medtronic, Minimed, 770g, Insulin Pump, System, Patients, Receives, Smartphone, Type 1 Diabetes, US

19. Gilead Signs an Exclusive License Agreement with Jounce for Cancer Immunotherapies

Published: Sept 02, 2020 | Tags:  Exclusive, Cancer, Immunotherapies, Gilead, Jounce, License, Agreement

20. Roche’s cobas HIV-1/HIV-2 Qualitative Test Receives the US FDA’s Approval to Detect HIV Infection

Published: Sept 02, 2020 | Tags: approval cobas 6800/8800 Systems FDA HIV-1/HIV-2 Qualitative Test receives Roche

21. Roche’s Enspryng (satralizumab) Receives Health Canada Approval for Neuromyelitis Optica Spectrum Disorder

Published: Sept 02, 2020| Tags: Authorizes, Ensprying, Health Canada, Neuromyelitis Optica Spectrum Disorder, Roche

22. AstraZeneca Expands Supply Agreement with Oxford Biomedica for AZD1222 to Combat COVID-19

Published: Aug 31, 2020| Tags: AstraZeneca, AZD1222, COVID-19, Expands, Oxford BioMedica, Supply, Agreement

23. GSK and VIR Biotechnology Initiate P-II/III COMET-ICE Study of VIR-7831 Against COVID-19

Published: Aug 31, 2020 | Tags: Against, COVID-19, GSK, Initiate, P-II/III, COMET-ICE, Study, Vir Biotechnology, VIR-7831

24. AstraZeneca Expands the Development of AZD1222 into P-III Study in the US Across All Adult Age Groups

Published: Aug 31, 2020 | Tags: Across, Age, Adult, AstraZeneca, AZD1222, Development, Expands, Groups, P-III, US

25. Johnson & Johnson Collaborates with the Government of Canada to Supply its Ad26.COV2.S for COVID-19

Published: Aug 31, 2020 | Tags: Ad26.COV2.S, Collaborates, Government of Canada, Johnson & Johnson, Supply

26. Ionis to Acquire Remaining Stake in Akcea Therapeutics for $18.5/share

Published: Aug 31, 2020 | Tags: $18.5/share, Acquire, Akcea Therapeutics, Ionis, Remaining, Stake

27. Mylan and Biocon Launch Semglee (insulin glargine injection) as Vials and Pre-Filled Pen in the US

Published: Aug 31, 2020 | Tags: Insulin Glargine injection, Biocon, Launch, Mylan, Pre-Filled, Pen, Semglee, US Vials

28. Cadila Launches Cadalimab (biosimilar, adalimumab) in India

Published: Aug 31, 2020 | Tags: Adalimumab, Biosimilar, Cadalimab, Cadila, India, Launches

29. AstraZeneca Reports Results of Farxiga (dapagliflozin) in P-III DAPA-CKD Trial for Patients With and Without Type-2 Diabetes

Published: Aug 31, 2020 | Tags: Dapagliflozin, AstraZeneca, DAPA-CKD, Trial, Farxiga, P-III, Reports, Results, Type-2 Diabetes

30. World’s First App-Based Nicotine Addiction Treatment Receives the MHLW’s Approval in Japan

Published: Aug 29, 2020 | Tags: Approved, Asia, CO Checker, CureApp, Digital Therapeutic, First, Prescription, Japan, Nicotine Addiction, Treatment, App, Receives, Regulatory, Approval

31. Novartis Reports Results of LNP023 in P-II Study for Paroxysmal Nocturnal Hemoglobinuria

Published: Aug 31, 2020  | Tags: LNP023, Novartis, P-II, Paroxysmal Nocturnal Hemoglobinuria, Reports Results,

Tuba Khan

Tuba Khan is an Editor and Digital Marketing expert at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in Lifesciences industry. She covers Pharma, Medical devices, Diagnostics and Digital health segment. Tuba also has an experience of digital and social media marketing and can run the campaign independently. She is also certified as a Digital marketer and social media marketer. She can be contacted on tuba@pharmashots.com

Related post